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Abstract: Ascites, being an accumulation of
excess fluid within the peritoneal cavity, is
most frequently encountered in patients with
cirrhosis or certain other diseases such as
congestive cardiac failure, peritoneal
tuberculosis and some primary or secondary
peritoneal tumours. This study included 17
patients (5 females, 12 males) with
malignant ascites (MA) and 23 patients (13
females, 10 males) with nonmalignant ascites
(NMA). We aimed to determinet the values
for total sialic acid (SA), pH, cholesterol,
fibronectin, total protein concentrations and
lactate dehydrogenase (LDH) activity in ascitic
fluid for the differential diagnosis of ascites.
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While total SA, fibronectin, cholesterol, LDH
and total protein values in MA cases were
found to be higher (p<0.05, p<0.001,

Introduction
The accumulation of fluid within the peritoneal cavity
is a common clinical finding with a wide range of causes
(1). There are no distinctive features and no single
diagnostic test is accurate in differentiating MA from
NMA (2). Recent studies have drawn attention to the
surface properties of cancer cells, suggesting new
possible markers of malignant effusions. Lipids, mainly
cholesterol and fibronectin, a glycoprotein derived from
the extracellular matrix, have been found to be elevated
in MA (2-4). SA is a common terminal saccharine of cell
surface constituents (glycoproteins and glycolipids) (2). It
has been found in elevated concentration in neoplastic
cells taken from breast, lung, stomach, colon, ovary,
prostate and liver tumours. In these malignancies,
sialoglycoprotein and sialoglycolipid concentrations are
often elevated in the blood as well because of shedding or
secretion by tumour cells (5). Fibronectin is a
glycoprotein of high molecular weight present in plasma
and other body fluids and tissues (6, 7). Fibronectin plays
an important role in diverse biological phenomena

p<0.05, p<0.05 and p<0.05 respectively),
pH values were lower (p<0.05) in the MA
group than in the NMA group. From these
parameters, fibronectin proved to be the
most specific and total SA proved to be the
most sensitive test for differential diagnosis
of ascites.
It was is concluded that the measurements of
total SA, cholesterol and fibronectin in ascitic
fluid may be useful for differential diagnosis
and appropriate treatment of ascites. The use
of these three parameters, in combination,
may provide higher sensitivity and specificity
for the differentiation of MA.

Key Words: Sialic acid, Ascitic fluid,
cholesterol, fibronectin, pH.

including cell adhesion, cell migration, embryonic
development, wound healing and homeostasis as well as
in the pathogenesis of such diseases as cancer and
bacterial infection (8, 9). Malignant, transformed cells
may shed their matrix fibronectin (6), which may then be
found in the body fluids. We have assessed the value of
measuring the fibronectin, total SA, pH, cholesterol, total
protein and LDH values of ascitic fluid in the diagnosis
of malignant ascites.
Materials and Methods
We studied 40 consecutive patients admitted because
of ascites of unknown origin. There were 23 NMA
patients (10 male, 13 female, mean age 50.7 yrs). Of
these patients, 12 had cirrhosis of the liver, 7 had right
heart failure, 2 had chronic renal failure, 1 patient with
ulcerative colitis and 1 patient with nephrotic syndrome.
There were 17 MA patients (12 male, 5 female, mean
age 49.8 yrs). Of these patients, 4 had carcinoma of the
stomach, 3 had hepatocelluler carcinoma, 4 had
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intraperitoneal lymphoma, 2 had cholangiocarcinoma, 2
had cancer of the bladder, 1 had colonic carcinoma and 1
had pancreal cancer. Diagnoses were confirmed by biopsy.
None of the NMA patients had any malignancy. Diagnostic
paracentesis was performed on every patient 24 hours
after admission to the hospital and before the beginning
of any treatment. Part of the sample was sent for
bacteriologic examination. For determination of pH, 5 ml
of ascitic fluid was collected anaerobically in a nonheparinized plastic syringe, and analyzed on a blood gas
analyzer (Nova, USA). The fibronectin concentration was
determined with commercial kits of antibody against
human fibronectin (Boehringer Mannheim, Germany).
Total SA was determined by enzymatic-colorimetric assay
(Boehringer Mannheim, Germany). Determination of LDH
and cholesterol was performed by autoanalyzer (Hitachi
717, Japan). Total protein concentration was determined
Table 1.

The results of analyses of MA and NMA

Parameter

NMA (x±SD)

pH

7.5±0.14

7.3±0.18

p<0.05

251.4±264

459.0±294

p<0.05

Fibronectin (µg/ml)

45.9±67

152.2±97

p<0.001

Cholesterol (mg/dl)

32.5±34

47.4±27

p<0.05

LDH (U/l)

40.3±46

172.0±321

p<0.05

Total protein (gr./dl)

2.2±1.71

3.1±1.70

p<0.05

Sialic acid (mg/l)

MA (x±SD)

*p

*NMA vs. MA

Parameter

True

False

Positive

Positive

13/17

6/23

76%

11/17

2/23

7/17

pH (≤7.45)

Specificity

Statistical Analysis
Values are expressed as mean ± SD. The significance
of the mean differences between groups was assessed by
the Student’s two-tailed unpaired t test. The correlation
coefficient was determined by linear regression analysis.
Differences were considered significant at p<0.05. For
each parameter we also calculated the sensitivity,
specificity, predictivity (of a positive test) and diagnostic
accuracy.
Results
There were significant differences between the MA
group and the NMA group in values for fibronectin, total
SA, pH, LDH, total protein and cholesterol levels. Results
are summarized in Table 1. Ascitic concentrations of total
SA above 300 mg/L (the cut-off value 16) were found in
6 patients with NMA and in 13 patients with MA
(sensitivity 76%; specificity 73%; predictivity of positive
test 68% and diagnostic accuracy 75%) (Table 2). Ascitic
concentrations of fibronectin higher than 100 mg/ml (the
cutoff value was 4.9) were found in 2 patients with NMA
and in 11 patients with MA (sensitivity 64%; specificity
91%; predictivity of positive test 84% and diagnostic
accuracy 80%). Table 2 shows a comparison of the
diagnostic accuracy of the parameters which seemed to
be useful for separating MA from NMA. We found a
significant positive correlation between ascitic
concentration of fibronectin and SA in the MA group
(r=0.517, p<0.05; Figure 1). A significant correlation
Positive

Diagnostic

predictivity

accuracy

73%

68%

75%

64%

91%

84%

80%

4/23

41%

82%

63%

65%

8/17

4/23

47%

82%

66%

67%

LDH (≥150 U/l)

4/17

3/23

23%

86%

57%

60%

T.prot (≥3gr/dl)

9/17

7/23

52%

69%

56%

62%

Sialic acid

Sensitivity

by sulphosalycilic acid. We selected the cutoff values for
each test according to the data of previous studies (2, 6,
9, 23).

(≥300 mg/l)
Fibronectin
(≥100 µg/ml)
Cholesterol
(≥45mg/dl)
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Table 2.

In differential of NM and NMA
diagnostic values of some
parameters
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Figure 1.

Correlation between SA and
Fibronectin in patients with
MA (r=0.517;p<0.05)

Figure 2.

Correlation between SA and
Cholesterol in patients with
MA (r=0.679;p<0.01).
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between ascitic concentration of cholesterol and SA was
found in both MA and NMA (r =0.679, p<0.01 for MA;
r = 0.587, p<0.01 for NMA; Figure 2 and 3,
respectively).
Discussion
Ascites may be caused by various diseases, the most
common of which are chronic liver disease and
malignancy. Attempts to achieve a complete
differentiation of patients with MA and NMA by means of
a simple laboratory test have so far failed (6). We studied
40 consecutive patients with ascites, 23 of which had
benign disease and 17 malignancy. We found no patient
with infected ascites. Ascitic fluid total protein levels were

higher in malignant patients than in non malignant
patients, while sensitivity and specificity were low. These
findings support the view of various investigators that
protein concentration is not a definite criterion for
differentiating MA from NMA. The ascitic LDH levels of
MA patients were significantly higher than those of NMA
patients. The sensitivity of ascitic LDH was low (23%).
Our findings were in agreement with the findings of other
researchers (4, 6, 10). Also as in previous studies (6, 7,
11), a significantly lower pH value was found in the MA
group than in the NMA group. Rovelstad et al. (19)
reported elevated total lipid concentrations in the ascites
of patients with malignant neoplasms. This was later
mentioned by other researchers (2, 15, 16, 20-22).
Furthermore, our results show that the cholesterol level
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Figure 3.
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Correlation between SA and
Cholesterol in patients with
NMA (r=0.587;p<0.01).

120

Cholesterol (mg/dL)

100
80
60
40
20
0
0

200

200

600

800

1000

1200

1400

Sialic Acid (mg/L)

in ascitic fluid of patients with malignancies is significantly
high, a finding that is in accordance with previous results.
The pathogenesis of increased cholesterol level in
malignant ascites was not completely explained. However,
based on previous studies, it was thought that the source
of cholesterol originated from malignant cell membrans
(13).
Malignant transformed cells may shed matrix
fibronectin (6) which may then be found in the body
fluids. The ascitic fibronectin level was the most specific
test for malignancy of the various tests evaluated (91%).
The specificity is similar to that reported by Colli et al.
(93%) (7), and superior to the 88% reported by Gerbes
et al. (23), but inferior to the 100% accuracy observed
by Schölmerich (6) and Archimandritis et al. (24) and the
98% observed by Prieto et al. (15). It should be noted
that the cutoff levels for malignancy were different in the
five studies mentioned. Although many cell types have the
capacity to synthesize and secrete fibronectin, several
lines of evidence suggest that most, if not all, circulating
fibronectin is produced by hepatocytes. Therefore,
patients with decompensated cirrhosis of fulminate
hepatic failure have low concentrations of plasma

fibronectin (10). In our study, we found fibronectin levels
above 100 µg/ml in only 1 out of 12 patients with
cirrhosis and in only 1 out of 7 patients with congestive
cardiac failure. All other NMA patients had low levels of
fibronectin. SA is a common terminal saccharide in
glycoproteins and glycolipids found on membrane
surfaces. SA concentration has been reported to be higher
in cancer cells obtained from tumors. The concentrations
of sialoglycoprotein and sialoglycolipid are frequently high
because of their secretion by tumor cells both in blood
and ascitic fluid (2). We found higher concentrations of
total SA in the MA group than in the NMA group and,
taking 300 mg/l as the cut-off value (2), found the false
positive levels to be 6 out of 23, the false negative levels
to be 4 out of 17 and the overall diagnostic accuracy to
be 75%. The sensitivity found in the study was higher
than that found by Colli et al. (2) while the specificity was
lower. This difference may be due to different disease
groups. There were statistically significant correlations
between total SA and cholesterol, and total SA and
fibronectin. These findings may indicate that cholesterol,
total SA, and fibronectin are synthesized and secreted
from malignant cells.
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